Gebeyehu Tessema Azibte

Dr. Gebeyehu Tessema Azibte

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2024 in Surgery in Practice and Science
Verified
Journal Article
Open access
EBEyob Asefa Bekele
Eyob Asefa Bekele
TTTseganesh Berhanu Tulu
Tseganesh Berhanu Tulu
YBYonathan Abebe Bulto
Yonathan Abebe Bulto
GAGebeyehu Tessema Azibte
Gebeyehu Tessema Azibte
WBWaltengus Birhanu
Waltengus Birhanu
Pain, as defined by the International Association for the Study of Pain, is an unpleasant sensory and emotional experience associated with, or resembling, that is associated with actual or potential tissue damage. In Ethiopia, where healthcare facilities and offerings are expanding to handle countless patients requiring surgical intervention, managing acute postoperative pain is a serious concern. To assess the prevalence of acute postoperative pain and associated factors after elective surgery among adult patients at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia, 2023 This is an institution-based cross-sectional study. A structured data collection format was used to collect data from 219 participants. Bivariable and multivariable logistic regression analyses described the association between independent and dependent variables. Of 219 patients, 180 (82.2 %) had acute postoperative pain. The prevalence of moderate to severe pain was 34.24 %. Preoperative anxiety, the use of intraoperative analgesics, and duration of surgery were the main factors associated with the prevalence of acute postoperative pain. Our study revealed that the overall prevalence of postoperative pain was relatively low in the study area. This suggests that the attention given to postoperative pain recognition and management is better than that in other areas. However, the finding of a significant gap in managing postoperative pain underscores the need for further improvements in pain management practices. This should motivate us to commit to change, particularly in the identified areas of concern, such as preoperative anxiety, use of intraoperative analgesics, and duration of surgery.

4 July 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
EAEskedar Ferdu Azerefegne
Eskedar Ferdu Azerefegne
GAGebeyehu Tessema Azibte
Gebeyehu Tessema Azibte
FBFitsum Seyoum Bekele
Fitsum Seyoum Bekele
Kehabtimer Shiferaw KotisoKehabtimer Shiferaw Kotiso
Kehabtimer Shiferaw Kotiso
BABerhanu Moges Abera
Berhanu Moges Abera
WDWondwossen Amogne Degu
Wondwossen Amogne Degu
Patients with hematologic malignancies are susceptible to neutropenic fever, a potentially life-threatening condition. This study investigated the association between clinical profiles, treatment, and outcomes in these patients. A retrospective analysis of 132 patients with first-time neutropenic fever and hematologic malignancy diagnosed at Tikur Anbessa Specialized Hospital, Ethiopia, between 2019-01-01 and 2019-12-31 was conducted. Data on demographics, underlying malignancy, presumed infection site, treatment, and 30-day mortality were collected. ale predominance (13:10) was observed. Acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) were the most common malignancies (43.2% and 40.9%, respectively). Chest focus of infection was the most frequent primary source (33%). Cefepime and Vancomycin combination therapy was used in 40.9% of patients. Prior febrile neutropenia and medical ICU admission during treatment significantly increased the odds of 30-day mortality (adjusted odds ratio 3.8 and 5.4, respectively). This study highlights the crucial role of prior febrile neutropenia and medical ICU admission in predicting mortality within 30 days of neutropenic fever diagnosis in patients with hematologic malignancies.

7 September 2025 in JGH Open
Verified
Journal Article
Open access
MSMohammed Momin Sugie
Mohammed Momin Sugie
GAGebeyehu Tessema Azibte
Gebeyehu Tessema Azibte
AAAhmed Adem
Ahmed Adem
ALAsnake Limenhe
Asnake Limenhe
BLBiruk Abate Legesse
Biruk Abate Legesse
ZAZekarias Seifu Ayalew
Zekarias Seifu Ayalew
Background: Global evidence has observed that individuals with inflammatory bowel disease (IBD) are at a heightened risk of experiencing psychiatric disorders, which often coincide with a decrease in their quality of life.Objective: To assess the prevalence of anxiety and depression symptoms and associated factors among patients with IBD.Methods: An institutional‐based cross‐sectional study was conducted at Tikur Anbesa Specialized Hospital and Adera Medical Center. Categorical variables were presented using frequency and percentage and compared between groups using the chi‐square test. The normal distribution of the continuous variables was assessed using the Shapiro–Wilk test. Mean and standard deviation were calculated for normally distributed data, while the median and interquartile range were calculated for skewed data. We used univariate and multivariate binary logistic regression analysis to examine the factors associated with depression and anxiety; results were reported as adjusted odds ratios (OR) with 95% confidence intervals and p value < 0.05 considered statistically significant.Results: The prevalence of anxiety and depression was 5.1% and 7.1%, respectively, in IBD. Moderate disease activity (AOR = 16.1 (1.7, 156.7), p = 0.015) and severe disease activity (AOR = 49.8 (2.1, 1144.02), p = 0.014) had a statistically significant association with increased rates of depressive symptoms. Moderate disease activity (AOR = 9.9, 95% CI: 0.9, 106.2, p = 0.058) had a positive association. Severe disease activity (AOR = 45.3, 95% CI: 2.0, 1018.0, p = 0.016) has a significant associated factor with having anxiety symptoms.Conclusion: The prevalence of anxiety and depressive symptoms in this study was generally low but can increase due to important factors such as disease activity, smoking, unemployment, a short duration after diagnosis, and having ulcerative IBD.

1 August 2024 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
BLBiruk Abate Legesse
Biruk Abate Legesse
BABecky Abdissa Adugna
Becky Abdissa Adugna
ZAZekarias Seifu Ayalew
Zekarias Seifu Ayalew
GAGebeyehu Tessema Azibte
Gebeyehu Tessema Azibte
SASeid Ibrahim Abdulkadir
Seid Ibrahim Abdulkadir
AGAron Berhanu Gudetta
Aron Berhanu Gudetta

31 July 2024 in eJHaem
Verified
Journal Article
Open access
ZAZekarias Seifu Ayalew
Zekarias Seifu Ayalew
GAGebeyehu Tessema Azibte
Gebeyehu Tessema Azibte
FTFisihatsion Tadesse
Fisihatsion Tadesse
BLBiruk Abate Legesse
Biruk Abate Legesse
ZKZerubabel Getahun Kiflu
Zerubabel Getahun Kiflu
AEAddisu Melkie Ejigu
Addisu Melkie Ejigu
Introduction: The efficacy of BCR‐ABL tyrosine kinase inhibitors (TKIs) in treating chronic myelogenous leukemia and other malignancies is well‐documented. However, concerns about potential nephrotoxicity have raised questions. This study, conducted at Tikur Anbesa Specialized Hospital (TASH) in Addis Ababa, Ethiopia, aimed to investigate the association between TKIs and renal toxicities.Methods: A hospital‐based cross‐sectional design was used to enroll 260 TASH patients actively receiving BCR‐ABL TKIs. Demographic information, diagnoses, treatment details, and laboratory test results were collected for each participant's Electronic Medical Record. The primary goal was to assess adverse renal events, a combination of events of a decrease in estimated glomerular filtration rate (eGFR) exceeding 30% from baseline, significant proteinuria, and a diagnosis of acute kidney injury (AKI) or chronic kidney disease (CKD). A logistic regression model was used to analyze the data and identify factors associated with developing adverse renal events.Results: Our analysis revealed a statistically significant decrease in eGFR following treatment with TKIs. However, the observed rate of adverse renal events (13.1%) was lower than reported in some previous studies. Factors significantly associated with adverse renal events included longer TKI duration, male sex (protective), hypertension, HIV infection, and achieving complete molecular remission and/or a complete hematologic response. No significant associations were found with diabetes mellitus, age, angiotensin‐converting enzyme inhibitors use, or baseline creatinine level.Conclusions: While this study found that BCR‐ABL TKIs can lead to a decline in eGFR, AKI, and CKD, it also demonstrated that they were relatively safer in our study population.

4 December 2024 in Gastroenterology and Functional Medicine
Verified
Journal Article
Open access
PDF file
DTDawit Habtie Tegegne
Dawit Habtie Tegegne
GRGuda Merdassa Roro
Guda Merdassa Roro
GAGebeyehu Tessema Azibte
Gebeyehu Tessema Azibte
ZAZekarias Seifu Ayalew
Zekarias Seifu Ayalew
BMBereket Abraha Molla
Bereket Abraha Molla
EOEman Omer
Eman Omer
Background and Objectives: Long-term antiviral use can suppress hepatitis B virus (HBV) DNA, normalize liver function tests, reverse fibrosis and cirrhosis, and improve histological changes. Understanding adherence and the factors affecting it is crucial for managing chronic hepatitis B virus (CHB) patients, achieving sustained suppression with low drug resistance risk, and developing strategies to address poor adherence. This study aims to assess antiviral medication adherence and factors associated with adherence among HBV patients on treatment at the gastroenterology clinic in Tikur Anbessa Specialized Hospital (TASH). Methods: A cross-sectional study was conducted in 149 HBV patients undergoing therapy at TASH from May 2023 to February 2024. The medication adherence level was assessed using Morisky’s 8-item medication adherence questionnaire. Data was entered into Epi Info 7 for database construction and exported to SPSS version 26. Different statistical analyses were used, including frequencies of variables and descriptive statistics. An ordinal logistic regression analysis was used to identify factors associated with medication adherence levels. The proportional odds model (POM) assumptions were checked using chi-square and parallel line tests. Results: The study found that only 32.2% participants had high adherence, 39.6% had medium adherence, and 28.2% had low adherence. Rural dweller (a POR: 2.4; 95%CI: 1.09 to 5.20), low educational level (a POR: 3; 95%CI: 1.27 to 7.13), being unmarried (a POR: 2.52; 95%CI: 1.15 to 5.50), not being counseled about medication adherence by treating physicians (a POR: 3.2; 95%CI: 1.61 to 6.50), and an abnormal liver function tests (a POR: 2.31; 95%CI: 1.08 to 4.92) were significantly associated with medium or low medication adherence level. Conclusion: The study reveals low medication adherence rates among participants, with only a minority demonstrating high adherence. Factors such as rural dwellings, low educational level, being unmarried, lack of counseling, and abnormal liver function tests were significantly associated with medium or low adherence. Targeted interventions are needed to improve adherence, especially for individuals in rural areas with lower education levels and who are unmarried. Efforts should be made to integrate medication adherence discussions into routine healthcare visits and raise physician awareness about counseling patients on adherence are crucial.